Caricamento...

Extended interval dosing of natalizumab: a two-center, 7-year experience

BACKGROUND: The enthusiasm for natalizumab, a highly efficacious agent in the treatment of multiple sclerosis (MS), has been tempered by the risks of progressive multifocal leukoencephalopathy associated with its use, and strategies to minimize those risks are of great interest. Extended interval do...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bomprezzi, Roberto, Pawate, Siddharama
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2014
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4206618/
https://ncbi.nlm.nih.gov/pubmed/25342976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285614540224
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !